Cargando…
Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ult...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410168/ https://www.ncbi.nlm.nih.gov/pubmed/36013236 http://dx.doi.org/10.3390/jpm12081287 |
_version_ | 1784775028966948864 |
---|---|
author | Boice, Emily N. Berard, David Hernandez Torres, Sofia I. Avital, Guy Snider, Eric J. |
author_facet | Boice, Emily N. Berard, David Hernandez Torres, Sofia I. Avital, Guy Snider, Eric J. |
author_sort | Boice, Emily N. |
collection | PubMed |
description | Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ultrasound and robotics are being developed. Here, we present an ex vivo lower-body porcine model as a testing platform for evaluation of vascular devices and compare its features to commercially available platforms. While the commercially available trainers were simpler to set-up and use, the scope of their utility was limited as they were unable to provide realistic anatomic, physiologic, and sonographic properties that were provided by the ex vivo model. However, the ex vivo model was more cumbersome to set-up and use. Overall, both have a place in the development and evaluation pipeline for ACVADs before testing on live animals, thus accelerating product development and translation. |
format | Online Article Text |
id | pubmed-9410168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94101682022-08-26 Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance Boice, Emily N. Berard, David Hernandez Torres, Sofia I. Avital, Guy Snider, Eric J. J Pers Med Article Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ultrasound and robotics are being developed. Here, we present an ex vivo lower-body porcine model as a testing platform for evaluation of vascular devices and compare its features to commercially available platforms. While the commercially available trainers were simpler to set-up and use, the scope of their utility was limited as they were unable to provide realistic anatomic, physiologic, and sonographic properties that were provided by the ex vivo model. However, the ex vivo model was more cumbersome to set-up and use. Overall, both have a place in the development and evaluation pipeline for ACVADs before testing on live animals, thus accelerating product development and translation. MDPI 2022-08-05 /pmc/articles/PMC9410168/ /pubmed/36013236 http://dx.doi.org/10.3390/jpm12081287 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Boice, Emily N. Berard, David Hernandez Torres, Sofia I. Avital, Guy Snider, Eric J. Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance |
title | Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance |
title_full | Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance |
title_fullStr | Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance |
title_full_unstemmed | Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance |
title_short | Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance |
title_sort | development and characterization of an ex vivo testing platform for evaluating automated central vascular access device performance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410168/ https://www.ncbi.nlm.nih.gov/pubmed/36013236 http://dx.doi.org/10.3390/jpm12081287 |
work_keys_str_mv | AT boiceemilyn developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance AT berarddavid developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance AT hernandeztorressofiai developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance AT avitalguy developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance AT sniderericj developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance |